Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 18 04:00PM ET
1.09
Dollar change
+0.06
Percentage change
5.83
%
Index- P/E- EPS (ttm)-2.10 Insider Own13.06% Shs Outstand18.52M Perf Week-1.80%
Market Cap20.24M Forward P/E- EPS next Y-1.51 Insider Trans0.00% Shs Float16.15M Perf Month1.87%
Income-19.36M PEG- EPS next Q-0.36 Inst Own5.33% Short Float8.97% Perf Quarter2.83%
Sales0.00M P/S- EPS this Y84.38% Inst Trans27.07% Short Ratio3.48 Perf Half Y-58.71%
Book/sh1.18 P/B0.93 EPS next Y-32.46% ROA-67.31% Short Interest1.45M Perf Year-76.31%
Cash/sh1.25 P/C0.87 EPS next 5Y- ROE-93.23% 52W Range0.62 - 7.50 Perf YTD-45.50%
Dividend Est.- P/FCF- EPS past 5Y5.73% ROIC-87.56% 52W High-85.47% Beta1.15
Dividend TTM- Quick Ratio9.32 Sales past 5Y- Gross Margin- 52W Low75.81% ATR (14)0.08
Dividend Ex-Date- Current Ratio9.32 EPS Y/Y TTM78.12% Oper. Margin- RSI (14)51.52 Volatility5.27% 3.47%
Employees14 Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price6.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q92.46% Payout- Rel Volume0.45 Prev Close1.03
Sales Surprise- EPS Surprise0.00% Sales Q/Q- EarningsMay 28 Avg Volume415.97K Price1.09
SMA201.11% SMA509.22% SMA200-38.65% Trades Volume188,468 Change5.83%
Date Action Analyst Rating Change Price Target Change
Jul-22-22Initiated Cantor Fitzgerald Overweight $7
Jan-15-21Initiated B. Riley Securities Buy $47
May-15-25 08:00AM
May-14-25 07:30AM
May-07-25 08:00AM
May-05-25 08:00AM
Apr-16-25 08:00AM
08:00AM Loading…
Mar-27-25 08:00AM
Mar-10-25 10:35AM
Mar-03-25 08:40PM
Feb-22-25 12:15PM
Jan-13-25 09:00AM
Nov-20-24 08:00AM
Nov-04-24 08:00AM
Oct-29-24 04:05PM
Oct-28-24 04:10PM
03:13PM
04:10PM Loading…
Oct-24-24 04:10PM
Oct-23-24 03:24PM
09:19AM
08:00AM
Oct-22-24 04:01PM
Oct-21-24 03:08PM
Oct-15-24 08:00AM
Oct-11-24 09:00AM
Oct-01-24 08:00AM
Sep-25-24 04:05PM
Sep-23-24 10:26PM
04:05PM
Sep-16-24 08:00AM
Sep-03-24 08:00AM
Aug-27-24 08:45AM
08:00AM Loading…
Aug-13-24 08:00AM
Aug-12-24 07:30AM
Aug-08-24 06:00AM
Aug-06-24 04:40PM
Jul-05-24 09:00AM
Jun-25-24 08:00AM
Jun-21-24 09:00AM
Jun-20-24 08:00AM
Jun-12-24 08:24AM
Jun-04-24 08:00AM
May-22-24 08:00AM
May-15-24 10:53AM
Apr-29-24 11:43AM
08:00AM
Apr-25-24 08:00AM
Apr-18-24 08:00AM
Apr-12-24 09:00AM
Mar-26-24 10:30AM
Mar-13-24 11:30AM
Mar-12-24 09:55AM
09:41AM
Mar-11-24 10:48AM
08:00AM
Mar-06-24 06:21PM
05:00PM
Mar-05-24 11:39AM
Mar-04-24 05:16PM
08:51AM
01:32AM
Mar-01-24 04:58PM
04:58PM
10:57AM
08:00AM
Feb-23-24 04:49PM
12:30PM
05:45AM
Feb-19-24 01:12PM
Feb-09-24 03:40PM
Feb-07-24 01:00PM
Feb-06-24 08:00AM
Jan-29-24 01:28PM
Jan-27-24 05:29AM
Jan-25-24 12:34PM
Jan-24-24 11:30AM
Jan-19-24 07:18PM
Jan-17-24 03:14PM
Jan-11-24 10:25AM
Jan-05-24 02:08PM
09:00AM
Dec-29-23 09:00AM
Dec-25-23 11:15AM
Dec-22-23 09:00AM
Dec-21-23 10:25AM
Dec-18-23 02:32PM
Dec-13-23 04:36PM
Dec-11-23 09:35AM
Dec-04-23 03:23PM
Nov-30-23 02:21PM
10:20AM
Nov-29-23 11:38AM
09:34AM
08:00AM
Nov-13-23 08:00AM
Nov-10-23 09:00AM
Nov-02-23 08:00AM
Oct-30-23 01:00PM
08:00AM
Oct-26-23 08:00AM
Oct-25-23 12:30PM
Oct-19-23 10:00AM
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.